This dataset contains supplemental tables and tracks for the study entitled: "Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation". Files PMDs_CGIs The included files contain: - Genome positions of detected PMDs with their mean methylation (weighted mean, see Methods) - Genome positions of CpG islands with their mean methylation (weighted mean) - The "Brinkman" directory contains files from breast cancer data produced in this study - The "normals" directory contains files from normal tissues (external data) analyzed in this study - The "tumors" directory contains files from tumors (external data) analyzed in this study All genome positions are based on GRCh37/hg19 All files ...
Methylation of CpG islands within the DNA promoter regions is one mechanism that leads to aberrant g...
Aberrant CpG methylation changes occurring during tumour progression include the loss (hypomethylati...
Additional file 1: Table S1. Oligonucleotides used for MSD-AFLP. Table S2. Locus-specific primers us...
This dataset contains supplemental tables and tracks for the study entitled: "Partially methylated d...
Item does not contain fulltextThis dataset contains supplemental tables and tracks for the study ent...
This dataset contains supplemental tables and tracks for the study entitled: "Partially methylated d...
Global loss of DNA methylation and CpG island (CGI) hypermethylation are key epigenomic aberrations ...
Maintenance of CpG island methylation in the genome is crucial for cellular homeostasis and this bal...
While changes in DNA methylation are known to occur early in breast carcinogenesis and the landscape...
<p>(a) Methylation status of single CpGs in one genomic region covering 10% of chromosome 10 (hg18 h...
258 genes hypermethylated in more than 90% of all CIMP-H tumours. Two-hundred fifty eight CpG island...
CpG island hypermethylation is known to be asso-ciated with gene silencing in cancer. This epigeneti...
Promoter CpG islands are typically unmethylated in normal cells, but in cancer a proportion are subj...
Table S1. Clinical table of normal individuals and cancer patients. Table S2. Primer sequences. Tabl...
Robustness of methylation subtypes. Principal component analysis to monitor data bias due to technic...
Methylation of CpG islands within the DNA promoter regions is one mechanism that leads to aberrant g...
Aberrant CpG methylation changes occurring during tumour progression include the loss (hypomethylati...
Additional file 1: Table S1. Oligonucleotides used for MSD-AFLP. Table S2. Locus-specific primers us...
This dataset contains supplemental tables and tracks for the study entitled: "Partially methylated d...
Item does not contain fulltextThis dataset contains supplemental tables and tracks for the study ent...
This dataset contains supplemental tables and tracks for the study entitled: "Partially methylated d...
Global loss of DNA methylation and CpG island (CGI) hypermethylation are key epigenomic aberrations ...
Maintenance of CpG island methylation in the genome is crucial for cellular homeostasis and this bal...
While changes in DNA methylation are known to occur early in breast carcinogenesis and the landscape...
<p>(a) Methylation status of single CpGs in one genomic region covering 10% of chromosome 10 (hg18 h...
258 genes hypermethylated in more than 90% of all CIMP-H tumours. Two-hundred fifty eight CpG island...
CpG island hypermethylation is known to be asso-ciated with gene silencing in cancer. This epigeneti...
Promoter CpG islands are typically unmethylated in normal cells, but in cancer a proportion are subj...
Table S1. Clinical table of normal individuals and cancer patients. Table S2. Primer sequences. Tabl...
Robustness of methylation subtypes. Principal component analysis to monitor data bias due to technic...
Methylation of CpG islands within the DNA promoter regions is one mechanism that leads to aberrant g...
Aberrant CpG methylation changes occurring during tumour progression include the loss (hypomethylati...
Additional file 1: Table S1. Oligonucleotides used for MSD-AFLP. Table S2. Locus-specific primers us...